224 related articles for article (PubMed ID: 31561530)
1. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
[TBL] [Abstract][Full Text] [Related]
2. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
Lu GQ; Li XY; Mohamed O K; Wang D; Meng FH
Eur J Med Chem; 2019 Jun; 171():282-296. PubMed ID: 30927565
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido)benzoyl hydrazide derivatives as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
Li XY; Liang JW; Mohamed O K; Zhang TJ; Lu GQ; Meng FH
Eur J Med Chem; 2018 Jun; 154():267-279. PubMed ID: 29807332
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
[TBL] [Abstract][Full Text] [Related]
7. Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.
Cardinale D; Guaitoli G; Tondi D; Luciani R; Henrich S; Salo-Ahen OM; Ferrari S; Marverti G; Guerrieri D; Ligabue A; Frassineti C; Pozzi C; Mangani S; Fessas D; Guerrini R; Ponterini G; Wade RC; Costi MP
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E542-9. PubMed ID: 21795601
[TBL] [Abstract][Full Text] [Related]
8. Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth.
Saxena P; Severi L; Santucci M; Taddia L; Ferrari S; Luciani R; Marverti G; Marraccini C; Tondi D; Mor M; Scalvini L; Vitiello S; Losi L; Fonda S; Pacifico S; Guerrini R; D'Arca D; Ponterini G; Costi MP
J Med Chem; 2018 Aug; 61(16):7374-7380. PubMed ID: 30035541
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
10. A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.
Marverti G; Gozzi G; Maretti E; Lauriola A; Severi L; Sacchetti F; Losi L; Pacifico S; Ferrari S; Ponterini G; Leo E; Costi MP; D'Arca D
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585842
[TBL] [Abstract][Full Text] [Related]
11. Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growth.
Pelà M; Saxena P; Luciani R; Santucci M; Ferrari S; Marverti G; Marraccini C; Martello A; Pirondi S; Genovese F; Salvadori S; D'Arca D; Ponterini G; Costi MP; Guerrini R
J Med Chem; 2014 Feb; 57(4):1355-67. PubMed ID: 24450514
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase inhibition: a structure-based rationale for drug design.
Costi MP
Med Res Rev; 1998 Jan; 18(1):21-42. PubMed ID: 9436180
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, anticancer evaluation and docking studies of new pyrimidine derivatives as potent thymidylate synthase inhibitors.
Amin LHT; Shawer TZ; El-Naggar AM; El-Sehrawi HMA
Bioorg Chem; 2019 Oct; 91():103159. PubMed ID: 31382056
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents.
Du QR; Li DD; Pi YZ; Li JR; Sun J; Fang F; Zhong WQ; Gong HB; Zhu HL
Bioorg Med Chem; 2013 Apr; 21(8):2286-2297. PubMed ID: 23490159
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and
Alzhrani ZMM; Alam MM; Neamatallah T; Nazreen S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1116-1123. PubMed ID: 32354237
[TBL] [Abstract][Full Text] [Related]
16. Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach.
El-Mesallamy HO; El Magdoub HM; Chapman JM; Hamdy NM; Schaalan MF; Hammad LN; Berger SH
PLoS One; 2018; 13(3):e0193810. PubMed ID: 29538414
[TBL] [Abstract][Full Text] [Related]
17. Folate-based thymidylate synthase inhibitors as anticancer drugs.
Jackman AL; Calvert AH
Ann Oncol; 1995 Nov; 6(9):871-81. PubMed ID: 8624289
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase.
Sharma H; Landau MJ; Sullivan TJ; Kumar VP; Dahlgren MK; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2014 Feb; 24(4):1232-5. PubMed ID: 24440298
[TBL] [Abstract][Full Text] [Related]
19. Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.
Marverti G; Marraccini C; Martello A; D'Arca D; Pacifico S; Guerrini R; Spyrakis F; Gozzi G; Lauriola A; Santucci M; Cannazza G; Tagliazucchi L; Cazzato AS; Losi L; Ferrari S; Ponterini G; Costi MP
J Med Chem; 2021 Mar; 64(6):3204-3221. PubMed ID: 33710891
[TBL] [Abstract][Full Text] [Related]
20. Alanine mutants of the interface residues of human thymidylate synthase decode key features of the binding mode of allosteric anticancer peptides.
Tochowicz A; Santucci M; Saxena P; Guaitoli G; Trande M; Finer-Moore J; Stroud RM; Costi MP
J Med Chem; 2015 Jan; 58(2):1012-8. PubMed ID: 25427005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
